Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Apotex
Pharma
Merck KGaA expects Mavenclad generics to deal serious blow in US
After delivering solid growth in 2025, Germany’s Merck KGaA expects an onslaught of U.S. generics to its MS blockbuster Mavenclad this year.
Fraiser Kansteiner
Mar 5, 2026 11:30am
State AGs unveil opioid settlements totaling $720M
Jul 10, 2025 4:39pm
Apotex, Heritage fork over $49M to resolve price-fixing claims
Nov 1, 2024 10:28am
Supreme Court rejects Vanda's Hetlioz patent revival appeal
Apr 22, 2024 3:49pm
Apotex buys specialty drugmaker Searchlight in expansion move
Apr 3, 2024 12:41pm
Apotex and 2 others settle in long-running price-fixing suit
Jan 24, 2024 2:19pm
